Previous close | 207.94 |
Open | 204.77 |
Bid | 197.90 x 1200 |
Ask | 198.22 x 800 |
Day's range | 196.11 - 204.82 |
52-week range | 179.59 - 234.09 |
Volume | |
Avg. volume | 778,882 |
Market cap | 16.686B |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | 45.81 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.88 (1.39%) |
Ex-dividend date | 28 May 2024 |
1y target est | N/A |
Labcorp (LH) sets a strong foundation for the year ahead with its impressive performance in the first quarter of 2024.
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Robust Performance Amid Expansions and Strategic Acquisitions